Clinical Trial Update: Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating crizotinib in children with relapsed or refractory solid tumors and anaplastic large cell lymphoma has completed phases 1 and 2 wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Malignant Solid Neoplasm
• Neuroblastoma

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Malignant Solid Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-05